Pharmafile Logo

thinkemotive

- PMLiVE

Circassia seeks shift to AIM after failing LSE criteria

Move comes after the drug developer suffered a string of immunotherapy defeats

- PMLiVE

Beneluxa: the future of European market access?

Andrew McConaghie talks to Beneluxa’s Marcel van Raaij and Biogen’s Erik Smet about their groundbreaking deal on Spinraza and what it means for European market access

- PMLiVE

Fishawack acquires Blue Latitude Health

Consultancy latest in string of strategic acquisitions for Fishawack

- PMLiVE

Axovant drops last ‘legacy’ drug to focus on gene therapies

Decision comes after nelotanserin failed to meet efficacy target

- PMLiVE

FDA clears Sandoz and Pear’s Opioid Use Disorder app

The app incorporates CBT to improve high relapse rates

- PMLiVE

As May delays, industry warns again of ‘no-deal’ Brexit

Brussels offers warm words, but no renegotiation

- PMLiVE

Healthcare excellence celebrated at 2018 HSJ Awards

Thousands of healthcare professionals were in attendance, all eager to scoop one of the coveted prizes from the world’s largest healthcare awards programme.

Wilmington Healthcare

- PMLiVE

Better together when buying medicines? Taking stock of the BeNeLuxA initiative

‘With Ireland being the latest to join in June 2018, there is clearly interest in the initiative that goes beyond the founding countries’

Report: Achieving launch excellence in the challenging healthcare markets of today

Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Blue Latitude Health

NHS medicines optimisation milestone

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry

Wilmington Healthcare

- PMLiVE

New Pfizer UK leader as Nordkamp moves into European role

Ben Osborn to take on managing director role

- PMLiVE

eConsent: Busting regulatory myths

‘eConsent improves the way consent is obtained, helps keep participants better informed and easily tracks study progress results’

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links